ATE393626T1 - Transnasale anticonvulsive zusammensetzungen - Google Patents

Transnasale anticonvulsive zusammensetzungen

Info

Publication number
ATE393626T1
ATE393626T1 AT00947610T AT00947610T ATE393626T1 AT E393626 T1 ATE393626 T1 AT E393626T1 AT 00947610 T AT00947610 T AT 00947610T AT 00947610 T AT00947610 T AT 00947610T AT E393626 T1 ATE393626 T1 AT E393626T1
Authority
AT
Austria
Prior art keywords
compositions
transnasal anticonvulsive
transnasal
anticonvulsive compositions
anticonvulsive
Prior art date
Application number
AT00947610T
Other languages
English (en)
Inventor
Yong-Moon Choi
Lianli Li
Kwon-Ho Kim
Original Assignee
Sk Holdings Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Holdings Co Ltd filed Critical Sk Holdings Co Ltd
Application granted granted Critical
Publication of ATE393626T1 publication Critical patent/ATE393626T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00947610T 1999-07-26 2000-07-24 Transnasale anticonvulsive zusammensetzungen ATE393626T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14559099P 1999-07-26 1999-07-26

Publications (1)

Publication Number Publication Date
ATE393626T1 true ATE393626T1 (de) 2008-05-15

Family

ID=22513768

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00947610T ATE393626T1 (de) 1999-07-26 2000-07-24 Transnasale anticonvulsive zusammensetzungen

Country Status (16)

Country Link
US (2) US6627211B1 (de)
EP (1) EP1196156B1 (de)
JP (1) JP4951723B2 (de)
KR (1) KR100715513B1 (de)
CN (1) CN1200697C (de)
AR (1) AR031072A1 (de)
AT (1) ATE393626T1 (de)
AU (1) AU778896B2 (de)
CA (1) CA2379365C (de)
DE (1) DE60038738T2 (de)
ES (1) ES2304969T3 (de)
MX (1) MXPA02001612A (de)
MY (1) MY124195A (de)
RU (1) RU2264209C2 (de)
TW (1) TWI269652B (de)
WO (1) WO2001006987A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2379365C (en) * 1999-07-26 2009-11-17 Sk Corporation Transnasal anticonvulsive compositions and modulated process
CN100421649C (zh) * 2003-06-17 2008-10-01 Sk株式会社 含地西泮的经鼻微乳
GB0321607D0 (en) * 2003-09-15 2003-10-15 Vectura Ltd Manufacture of pharmaceutical compositions
GB0400804D0 (en) 2004-01-14 2004-02-18 Innoscience Technology Bv Pharmaceutical compositions
PT1809273E (pt) * 2004-09-16 2010-05-10 Janssen Pharmaceutica Nv Utililização de 2-fenil-1,2-etanodiol-(di)carbamatos para tratamento de epileptogénese
KR20060030175A (ko) * 2004-10-05 2006-04-10 경북대학교 산학협력단 무정위성 운동 치료용 약학조성물
US8911751B2 (en) * 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
ATE544444T1 (de) * 2005-10-11 2012-02-15 Yissum Res Dev Co Zusammensetzungen für die nasale abgabe
TW200824693A (en) * 2006-08-28 2008-06-16 Jazz Pharmaceuticals Inc Pharmaceutical compositions of clonazepam and methods of use thereof
US7745430B2 (en) * 2006-11-15 2010-06-29 Sk Holdings Co., Ltd. Transnasal anticonvulsive pharmaceutical composition
US20080275030A1 (en) * 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
EP2121025B1 (de) * 2007-01-19 2016-11-02 Hananja Ehf Verfahren und zusammensetzungen zur abgabe eines therapeutischen mittels
US8530463B2 (en) 2007-05-07 2013-09-10 Hale Biopharma Ventures Llc Multimodal particulate formulations
CA2723470C (en) * 2007-05-07 2013-12-03 Hale Biopharma Ventures, Llc Nasal administration of benzodiazepines
EP2030610A1 (de) * 2007-08-31 2009-03-04 Archimedes Development Limited Nichtwässrige pharmazeutische Zusammensetzungen
TW200922635A (en) * 2007-08-31 2009-06-01 Archimedes Dev Ltd Non-aqueous pharmaceutical compositions
US8507468B2 (en) 2007-10-02 2013-08-13 Robert Orr Intranasal anti-convulsive compositions and methods
RU2370260C1 (ru) * 2008-03-17 2009-10-20 Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) (статус государственного учреждения) Противосудорожное средство
US20090258865A1 (en) 2008-03-28 2009-10-15 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
KR101517415B1 (ko) * 2008-05-14 2015-05-07 에스케이바이오팜 주식회사 난용성 항경련제를 함유하는 경비 항경련성 약학 조성물
SG193958A1 (en) * 2011-03-31 2013-11-29 Acorda Therapeutics Inc Intranasal benzodiazepine pharmaceutical compositions
EP2694076A4 (de) * 2011-04-01 2014-08-27 Cpex Pharmaceuticals Inc Nasalformulierungen aus benzodiazepin
PT3415139T (pt) 2011-06-14 2022-06-20 Neurelis Inc Administração de benzodiazepina
CN102836125A (zh) * 2011-06-23 2012-12-26 王晓青 治疗低血容量休克的丙戊酸及其盐的鼻腔给药制剂
JP2015227288A (ja) * 2012-08-31 2015-12-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 けいれん重積発作の治療用医薬組成物
WO2014127458A1 (en) * 2013-02-22 2014-08-28 Eastgate Pharmaceuticals Inc. Pharmaceutical composition for transmucosal administration of benzodiazepines
WO2017085687A1 (en) 2015-11-20 2017-05-26 West-Ward Pharmaceuticals International Limited Stable formulation of phenobarbital sodium injection
CN111278425B (zh) 2017-09-11 2024-06-11 耶路撒冷希伯来大学伊萨姆研究开发有限公司 用于向脑部经鼻给药药物和用于全身作用的组合物和方法
CN113855658A (zh) * 2021-04-08 2021-12-31 沙欣·法赞 用于治疗癫痫和相关病症的经鼻给药的药物组合物
CA3221395A1 (en) 2021-06-10 2022-12-15 Neurelis, Inc. Methods and compositions for treating seizure disorders in pediatric patients

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2573275B2 (ja) * 1986-03-10 1997-01-22 ブルグハルト,クルト 薬学的製剤及びその製造法
US4950664A (en) 1988-09-16 1990-08-21 Rugby-Darby Group Companies, Inc. Nasal administration of benzodiazepine hypnotics
DK0532546T3 (da) * 1990-05-10 1998-12-28 Nycomed Pharma As Farmaceutisk præparat indeholdende N-glycofuroler og N-ethylenglycoler
RU2118537C1 (ru) * 1995-10-02 1998-09-10 Государственный научный центр социальной и судебной психиатрии им.В.П.Сербского Способ лечения больных эпилепсией
WO1999011208A1 (en) * 1997-08-28 1999-03-11 Williams C Donald Method and composition for transdermal administration of pharmacologic agents
CA2379365C (en) * 1999-07-26 2009-11-17 Sk Corporation Transnasal anticonvulsive compositions and modulated process

Also Published As

Publication number Publication date
EP1196156A4 (de) 2005-01-12
DE60038738T2 (de) 2009-07-02
WO2001006987A3 (en) 2002-01-24
CN1200697C (zh) 2005-05-11
AR031072A1 (es) 2003-09-10
AU778896B2 (en) 2004-12-23
AU6118500A (en) 2001-02-13
RU2264209C2 (ru) 2005-11-20
JP4951723B2 (ja) 2012-06-13
TWI269652B (en) 2007-01-01
MY124195A (en) 2006-06-30
US6627211B1 (en) 2003-09-30
JP2003505403A (ja) 2003-02-12
MXPA02001612A (es) 2003-10-14
CA2379365A1 (en) 2001-02-01
EP1196156B1 (de) 2008-04-30
KR100715513B1 (ko) 2007-05-08
US7132112B2 (en) 2006-11-07
KR20020059583A (ko) 2002-07-13
WO2001006987A2 (en) 2001-02-01
DE60038738D1 (de) 2008-06-12
EP1196156A2 (de) 2002-04-17
CN1364079A (zh) 2002-08-14
CA2379365C (en) 2009-11-17
US20040028617A1 (en) 2004-02-12
RU2002104970A (ru) 2004-01-10
ES2304969T3 (es) 2008-11-01

Similar Documents

Publication Publication Date Title
DE60038738D1 (de) Transnasale anticonvulsive zusammensetzungen
AR023440A1 (es) Composiciones antitranspirantes
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
FI20105657L (fi) Farmaseuttisia koostumuksia
PT1242087E (pt) Composicoes farmaceuticas
DE60020342D1 (de) Tiefeindringende antimikrobielle zusammensetzungen
ITMI20010748A0 (it) Composizioni farmaceutiche
IS6120A (is) Lyfjablanda
ATE303787T1 (de) Schergelzusammensetzungen
EE200100414A (et) Valdekoksiibi kompositsioonid
AR028197A1 (es) Composiciones antitranspirantes
EA199900373A3 (ru) Фармацевтические композиции
ITMI991754A0 (it) Composizioni cosmetiche
ID29785A (id) Komposisi-komposisi sampo
ATE257691T1 (de) Schweisshemmende zusammensetzungen
DE60007530D1 (de) Oral wirksame androgene
DE60025624D1 (de) Farbstabile polyarylat enthaltende zusammensetzungen
ATE369830T1 (de) Schweisshemmende zusammensetzungen
NO20026123L (no) Farmasöytiske sammensetninger
IS6398A (is) Lyfjablöndur
ATE314049T1 (de) Schweisshemmende zusammensetzungen
DE60021259D1 (de) Reinigungsmittelzusammensetzungen
DE69943245D1 (de) Gaserzeugende zusammensetzung
PT1239832E (pt) Composicoes farmaceuticas
NO20031095D0 (no) Farmasöytiske sammensetninger

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties